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Abstract 37	
The initiation of puberty is orchestrated by an augmentation of gonadotropin-releasing 38	
hormone (GnRH) secretion from a few thousand hypothalamic neurons. Recent findings have 39	
indicated that the neuroendocrine control of puberty may be regulated by a hierarchically 40	
organized network of transcriptional factors acting upstream of GnRH. These include 41	
Enhanced At Puberty 1 (EAP1), which contributes to the initiation of female puberty through 42	
transactivation of the GnRH promoter. However, no EAP1 mutations have been found in 43	
humans with disorders of pubertal timing. We performed whole exome sequencing in 67 44	
probands and 93 relatives from a large cohort of familial self-limited delayed puberty (DP). 45	
Variants were analysed for rare, potentially pathogenic variants enriched in case-versus-46	
controls and relevant to the biological control of puberty. We identified one in-frame deletion 47	
(Ala221del) and one rare missense variant (Asn770His) in EAP1 in two unrelated families; 48	
these variants were highly conserved and potentially pathogenic. Expression studies revealed 49	
Eap1 mRNA abundance in peri-pubertal mouse hypothalamus. EAP1 binding to the GnRH1 50	
promoter increased in monkey hypothalamus at the onset of puberty as determined by 51	
chromatin immunoprecipitation (ChIP). Using a luciferase reporter assay, EAP1 mutants 52	
showed a reduced ability to trans-activate the GnRH promoter compared to wild-type EAP1, 53	
due to reduced protein levels caused by the Ala221del mutation and sub-cellular mis-location 54	
caused by the Asn770His mutation; as revealed by western blot and immunofluorescence, 55	
respectively.  56	
In conclusion, we have identified the first EAP1 mutations leading to reduced GnRH 57	
transcriptional activity resulting in a phenotype of self-limited DP. 58	
  59	
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Introduction  60	
Puberty represents the remarkable transition from childhood to adult life with the attainment 61	
of reproduction and adult stature. The onset of puberty is triggered by the re-activation of the 62	
hypothalamic-pituitary-gonadal (HPG) axis through augmentation of the pulsatile release of 63	
gonadotropin releasing hormone (GnRH) from the hypothalamus, which in turn causes an 64	
increased pulsatile gonadotropin release from the anterior pituitary. Pubertal onset shows a 65	
large variability among populations, due to ethnicity, environment, nutrition and stress, (1-3) 66	
although previous studies indicate that 60–80% of the variance in pubertal timing can be 67	
explained by heritable factors (4, 5). However, the precise mechanisms underlying the 68	
regulation of puberty onset are still unknown.  69	
In 2000, Rampazzo et al. (6) identified an intronless gene containing a zinc finger domain, 70	
mapped to 14q24.3 and provisionally named C14ORF4. Following functional annotation of 71	
C14ORF4 that indicated its pivotal role in pubertal timing, it was renamed Enhanced At 72	
Puberty-1 (EAP1) (7), and later was assigned the name of IRF2BPL (Interferon regulatory 73	
factor 2 binding protein-like). EAP1 mRNA has been shown to increase in the hypothalamus 74	
of rats and non-human primates at the time of puberty, and EAP1 deficiency led to delayed 75	
puberty (DP) and disrupted estrous cyclicity in both rodents (7) and non-human primates (8). 76	
Eap1 codes for a nuclear transcription factor, characterised by a dual transcriptional activity: 77	
it both trans-activates the GnRH promoter, which facilitates GnRH secretion, and inhibits the 78	
preproenkephalin promoter, which represses GnRH secretion. Therefore, Eap1 transcriptional 79	
activity facilitates the initiation of female puberty, in a manner that is independent of 80	
hypothalamic Kiss1 expression (9). Notably, a study performed in rats showed that 81	
hypothalamic expression of Eap1 is not directly regulated by ovarian steroids, as its 82	
expression in the peri-pubertal female hypothalamus changes even in the absence of ovaries 83	
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(10). Despite this seemingly important role, no EAP1 mutations have yet been identified in 84	
humans with pubertal disorders.  85	
DP is defined as the absence of testicular enlargement in boys or breast development in girls 86	
at an age that is 2 to 2.5 standard deviations (SD) later than the population mean (11). In 87	
absence of any identifiable cause, DP usually resolves by age 18 years, and in this case is 88	
referred to as self-limited, or constitutional, DP (12). Self-limited DP is commonly familial 89	
and segregates with an autosomal dominant inheritance patterns in >70% of families, 90	
indicating a strong genetic basis of the trait. Such an inheritance pattern suggests that DP has 91	
a mono- or oligogenic background, although very few underlying genes have been discovered 92	
(13).  Our large, well-phenotyped Finnish DP cohort (14) offers a prodigious tool to 93	
investigate potential pathogenic variants causing self-limited DP, likely enriched in our 94	
cohort. Indeed, comparable next generation sequencing strategies in patients from this cohort 95	
have unveiled roles for novel genes in the pathogenesis of self-limited DP (15, 16). 96	
In this study we have identified for the first time, two EAP1 mutations leading to reduced 97	
GnRH transcriptional activity resulting in the phenotype of self-limited DP.  98	
 99	
Results 100	
Exome sequencing of families with self-limited delayed puberty identifies variants in 101	
Enhanced At Puberty 1  102	
Whole exome sequencing of 67 informative families from our large cohort with self-limited 103	
DP returned 6,952,773 variants (Figure 1-A). These variants were filtered through our in-104	
house pipeline to identify rare, predicted deleterious mutations, segregating in multiple 105	
families and with potential biological relevance. The 28 top candidate genes identified then 106	
underwent targeted re-sequencing in additional 42 families from the same cohort (178 107	
6	
	
individuals with DP and 110 controls), and the filtered results were analysed by applying 108	
statistical thresholds for enrichment of rare, pathogenic variants in our cohort via whole gene 109	
rare variant burden testing (RVBT) with multiple comparison adjustment (17). Four genes 110	
passed the p<0.025 threshold on RVBT, and potentially pathogenic variants in these genes 111	
were further analysed to determine their presence in controls from our cohort and for 112	
segregation with trait (Figure 1-A).  113	
The candidate gene, Enhanced At Puberty-1 (EAP1) (ENSG00000119669, gene identification 114	
number 64207, Synonyms: Interferon Regulatory Factor 2 Binding Protein Like [IRF2BPL], 115	
Chromosome 14 Open Reading Frame 4 [c]), was identified after RVBT (adjusted p value = 116	
1.99E-05). EAP1 has been highlighted as an important potential candidate for the hierarchical 117	
regulation of pubertal timing through systems biology approaches and animal models (18). 118	
EAP1 mRNA levels and protein expression are seen to increase in the hypothalamus of 119	
primates and rodents at the time of pubertal onset (7).  120	
 121	
Two identified variants in EAP1 are rare, highly conserved and potentially damaging to 122	
protein function. 123	
Eight rare and potentially pathogenic variants were identified in EAP1 from whole and 124	
targeted exome sequencing. Five of these variants were discarded in our post-sequencing 125	
analysis, as they were present in multiple controls from our cohort. Three variants of interest 126	
in EAP1 were initially identified in 4 pedigrees from the cohort, but only 2 were found to 127	
segregate within families after Sanger sequencing of all family members. These 2 variants 128	
(NM_024496.3: c.2308A>C (rs760847179) p.Asn770His Chr: 14:77491828) and 129	
(NM_024496.3: c.661_663delGCG p.Ala221del Chr: 14:77493473) were each identified in 130	
one proband from the cohort and their affected family members. The two probands from 131	
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these pedigrees did not carry any other predicted pathogenic variants in known GnRH 132	
deficiency or gonadotropin deficiency causing genes (16). The two EAP1 variants, 133	
p.Asn770His and p.Ala221del, are both rare with MAF < 0.5% in population databases. Both 134	
variants affect amino acids that are highly conserved among homologues, as revealed by 135	
PhyloP score, and multiple sequence alignment (Figure 1-B). The p.Asn770His missense 136	
variant is predicted to be deleterious to protein function by prediction tools and CADD score, 137	
as the affected amino acid residue resides in a long loop region, which is C terminal to the 138	
C3HC4 ring domain (residues 715-762). This region shows evolutionary conservation among 139	
different species (Figure 1-C). Although the amino acid substitution (p.Asn770His) does not 140	
affect the residues directly involved in Zn binding and it is not predicted to reduce protein 141	
stability, it introduces a positively charged residue in place of a neutral one at a potential 142	
protein-protein interaction site and is thus likely to be disruptive. The p.Ala221del is a novel 143	
deletion located within a predicted disordered and glycine-proline rich region of the protein, 144	
but unfortunately no structural information could be obtained. 145	
 146	
Family members with classical self-limited DP from two pedigrees carry heterozygous 147	
EAP1 variants inherited in an autosomal dominant pattern 148	
Segregation with a clear autosomal dominant pattern of inheritance was seen in both the 149	
identified families, with the affected individuals carrying heterozygous changes in EAP1 150	
variants (Figure 2-A and B). The affected individuals from these two families have classical 151	
clinical and biochemical features of self-limited DP, with delayed onset of Tanner stage 2 and 152	
delayed peak height velocity (Figure 2-A’-A’’-B’-B’’). The proband from family A presented 153	
at age of 15.7 years with delayed pubertal development. His father had had similar delay in 154	
puberty onset. At initial evaluation the proband had testes volumes of 4 ml and circulating 155	
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testosterone concentration at early pubertal level (5.7 nmol/l). The proband from family B 156	
presented at age 15.3 years with pre-pubertal testes volumes of 3 ml bilaterally. Both 157	
probands had markedly delayed bone age at presentation and during follow up they had 158	
spontaneous pubertal development without testosterone therapy excluding idiopathic 159	
hypogonadotropic hypogonadism. 160	
 161	
Eap1 is expressed within key regions within the mouse adult hypothalamus 162	
We performed in situ hybridisation on peri-pubertal hypothalamus of male and female mice. 163	
An abundance of Eap1 mRNA was detected in the ventromedial (VMH), paraventricular (Pa) 164	
and arcuate (Arc) nuclei of male (Figure 3-A) and female mice (Figure 3-B). Eap1 expression 165	
was also investigated concurrently with the detection of GnRH neurons using 166	
immunohistochemistry. GnRH neuronal axons were mainly detected at the level of the 167	
median eminence (ME) (Figure 3-A) whereas GnRH neuron bodies were interspersed in the 168	
median preoptic area in a positive Eap1 milieu (Figure 3-C; Figure 3-D image shows GnRH 169	
neuron bodies at high magnification). Eap1 expression specificity was tested with a sense 170	
probe (Figure 3-E), which resulted in no detectable staining. Hence, Eap1 displayed strong 171	
expression in specific hypothalamic sub-regions of both female and male peri-pubertal mice. 172	
These results in mice are in keeping with Eap1 expression in rat and non-human primate 173	
hypothalami (7). Previous evidence showed GnRH neurons expressing Eap1 (7).  174	
 175	
EAP1 binding to the GnRH promoter increases at puberty 176	
Results of a chromatin immunoprecipitation (ChIP) experiment indicated that EAP1 binds to 177	
GnRH1 promoter (Figure 4), and that association of EAP1 to the GnRH1 promoter region in 178	
the MBH of female monkeys is increased at the late juvenile (LJ), as compared to the early 179	
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juvenile (EJ) period, i.e., at the initiation of puberty. No change in EAP1 binding was 180	
detected in intron 2 of the GnRH gene. ChIP also performed using an antibody to beta 181	
Galactosidase (not expressed in brain tissue), did not show any appreciable signal in either EJ 182	
or LJ animals. 183	
 184	
EAP1 variants significantly impair GnRH promoter activity in a dose dependent 185	
manner 186	
Previous results (7) together with evidence from our ChIP analysis, demonstrate that EAP1 187	
transcriptional activity is promoter specific. We therefore employed a promoter assay in order 188	
to study GnRH promoter activity when trans-activated by EAP1 WT or mutated constructs 189	
(Figure 5-A). In a HEK293T cell line, the trans-activating strength of EAP1 on the human 190	
GnRH promoter was significantly reduced by the p.Ala221del in frame deletion variant 191	
(adjusted p value=0.0374), and highly significantly reduced by the p.Asn770His missense 192	
variant (adjusted p value=0.0003), as compared to the WT protein. The deletion of the RING 193	
finger domain (RINGdel), which is required for EAP1 transcriptional activity (7), impairs the 194	
ability of EAP1 to trans-activate the GnRH promoter (adjusted p value=0.00021) and was 195	
used as a control (Figure 5-A).  In addition, as these are heterozygous mutations in our human 196	
patients, we co-transfected in equal amount the EAP1 WT expression vector with either the 197	
EAP1 Ala221del or with EAP1 Asn770His vectors, and we observed a dose-dependent 198	
reduction of EAP1 transcriptional activity (WT vs WT+Ala221del, adjusted p value =0.0498; 199	
WT vs WT+Asn770His, adjusted p value =0.0305).  200	
 201	
 202	
 203	
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EAP1 mutant proteins levels are altered compared to wild-type protein 204	
To further understand the mechanism by which these mutations affect protein function, we 205	
examined protein expression in a HEK293T cell line, which has no endogenous EAP1 206	
expression (Figure 5-B). EAP1 WT and mutated proteins were expressed (Figure 5-B) at the 207	
expected molecular weight of 90 KDa, whilst the RINGdel protein was expressed at 80 KDa, 208	
as expected due to the deletion of amino acids 715-762 (7). Densitometry analysis of the 209	
immunoblot (Figure 5-C), revealed that the Ala221del mutant protein levels, normalised to 210	
the housekeeping gene GAPDH, are significantly reduced compared to WT (adjusted p 211	
value=0.0062), thus explaining the reduced activity of this mutant protein. However, the 212	
Asn770His mutant protein levels are increased significantly (adjusted p value=0.0322). 213	
 214	
The EAP1 Asn770His mutant protein is mis-located in the cytoplasm 215	
EAP1 is a transcriptional factor that localises to the nucleus. To determine whether the 216	
Ala221del or Asn770His mutations affect the ability of EAP1 to reach the cell nucleus, we 217	
performed an immunocytoflourescence analysis (Figure 6) on HEK293T cells transiently 218	
transfected with EAP1 WT, Ala221del or Asn770His mutant vectors. The results showed that 219	
both the EAP1 WT protein and the Ala221del mutant are expressed in the nucleus, as 220	
evidenced by co-expression with the nuclear marker DAPI (Figure 6-C and F). In contrast, 221	
the Asn770His mutant protein failed to reach the nucleus, remaining in the cytoplasm (Figure 222	
6-I), hence providing a compelling explanation for the reduced functional activity of this 223	
mutant.  224	
 225	
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Discussion 226	
The central control of pubertal onset, after a period of juvenile quiescence, is mediated by a 227	
resurgence of the GnRH pulse generator, with a profound increase in the activity of the HPG 228	
axis. Although kisspeptin secretion from KNDy neurons in the arcuate nucleus is one of the 229	
most important stimulatory elements of this neural network, kisspeptin has not been 230	
demonstrated as the ultimate controller of the release of the puberty brake, but instead is 231	
likely to act as a conduit for upstream regulators (19). A growing body of evidence has 232	
demonstrated that no single gene alone is likely to be responsible for hypothalamic control of 233	
puberty. Instead, a sophisticated network of transcriptional factors, hierarchically organised, 234	
has been proposed as the machinery governing the balance between inhibitory and excitatory 235	
upstream inputs on the GnRH system (20). Transcriptional repression is a fundamental 236	
component of the regulation of mammalian gene expression, and transcriptional repressors 237	
containing zinc finger motifs, which recognise specific DNA sequences in regulatory regions 238	
of the genome, are particularly appealing candidates to have major roles in this governing 239	
network (21).  240	
In this study we have identified through whole and targeted exome sequencing two 241	
deleterious mutations in EAP1 in pedigrees with self-limited DP. Eap1 had been proposed in 242	
several animal studies to have an important role in regulating the time of puberty onset; 243	
however, mutations in this gene have not, to our knowledge, been previously identified in 244	
conditions of abnormal pubertal timing in humans. EAP1 mutations were significantly 245	
enriched in our cohort of patients with self-limited DP as compared to control populations, 246	
and these mutations were inherited in the expected autosomal dominant pattern seen in this 247	
condition (14, 22). The affected members of these families displayed typical self-limited DP 248	
with late onset of puberty, but full adult development by 18yrs of age. None of the affected 249	
individuals had neurological or other associated phenotypic abnormalities (23). 250	
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Complementing previous studies in rats and non-human primates (7), we have shown that 251	
Eap1 is also abundantly expressed in the peri-pubertal mouse hypothalamus. Previously 252	
published work provides evidence that GnRH neurons express Eap1 (7). Moreover, we have 253	
demonstrated that EAP1 binding to the GnRH1 promoter increases at the onset of puberty in 254	
female monkeys. In a previous rodent model siRNA-mediated Eap1 knockdown was shown 255	
to cause delayed vaginal opening in female rats in addition to disrupted estrous cyclicity, 256	
reduced plasma LH, FSH and estradiol levels, and delayed growth of ovarian follicles (7). In 257	
non-human primates knockdown of EAP1 expression in the ARC lead to cessation of 258	
menstrual cyclicity, and a single-nucleotide polymorphism in the 5'-flanking region of the 259	
EAP1 gene was associated with increased incidence of amenorrhea (8, 24). EAP1 has been 260	
shown to trans-activate the GnRH promoter, but reduce Kiss1 transcription (25). This 261	
evidence together highlights the role of EAP1 in regulating GnRH expression, and suggests 262	
that EAP1 may represent one of the main transcription factors contributing to the 263	
neuroendocrine control of female puberty.   264	
Both of the mutations identified here in humans with DP led to an impaired ability of the 265	
mutant EAP1 protein to trans-activate the human GnRH promoter, with a dose-dependent 266	
reduction in protein function seen in the in vitro heterozygous model (of 50% wild-type and 267	
50% mutant protein). Interestingly, one of the mutations identified led to reduced protein 268	
function secondary to decreased expression of the EAP1 protein, whilst the second resulted in 269	
mis-localisation of the mutant protein to the cytoplasm. 270	
Disturbances in pubertal timing affect over 4% of adolescents and are associated with adverse 271	
health outcomes. Specifically, DP patients are at risk of decreased bone mineral density, 272	
osteoporosis (26, 27) and psychological distress (28, 29). In addition, recently associated 273	
increased risk has been shown for outcomes such as cervical cancer, myocardial infarction 274	
and poor overall health (12, 30). Thus, the genetic control of human puberty is not only a 275	
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fascinating scientific puzzle, but also has potential for major health impact for patients with 276	
abnormal pubertal timing, both precocious and delayed. Moreover, as the understanding of 277	
the genetic basis of both self-limited and other causes of DP improves, it is likely that genetic 278	
testing will be able to help to establish a definitive diagnosis in cases, particularly where there 279	
is diagnostic difficulty. Rapid and efficient diagnosis of patients in clinic would represent a 280	
significant advancement in patient care and a likely economic advantage. 281	
In summary, we have identified two pathogenic mutations in the central transcriptional 282	
regulator EAP1 as the likely cause for self-limited DP in two families. Mutations in several 283	
genes known to influence GnRH secretion have been identified in patients with pubertal 284	
delay, including TAC3, TACR3, KISS1 and now, EAP1 (31-33). Our results strengthen the 285	
concept that EAP1 is a bone fide regulator of pubertal onset and add to the understanding of 286	
the regulatory neural network that controls the onset of human puberty. 287	
 288	
Material and methods 289	
Patients 290	
The cohort of individuals (n=910) we studied here has been described in previous reports (14-291	
16). Briefly, the cohort includes patients with self-limited DP (n=492), defined as the onset of 292	
Tanner genital stage II (testicular volume > 3 ml) >13.5 years in boys or Tanner breast stage 293	
II > 13.0 years in girls (i.e., two SD later than average pubertal development) (11) and their 294	
unaffected relatives. The patients were referred with a diagnosis of self-limited DP to a 295	
specialist paediatric care in Finland between 1982 and 2004. All patients met the diagnostic 296	
criteria for self-limited DP; medical history, clinical examination, and routine laboratory tests 297	
were reviewed to exclude those with chronic illness. Hypogonadotropic hypogonadism, if 298	
suspected, was excluded by spontaneous pubertal development at follow-up. 299	
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Family members of the DP patients participated via structured interviews and using archived 300	
height measurement records. The criteria for DP in probands’ family members were: 1) age at 301	
take-off, or 2) peak height velocity (PHV) occurring 1.5 SD beyond the mean; i.e. age at 302	
take-off exceeding 12.9 and 11.3 yrs, or age at PHV exceeding 14.8 and 12.8 yrs in males and 303	
females, respectively; or 3) age at attaining adult height more than 18 or 16 yrs, in males and 304	
females, respectively (34). Written informed consent was obtained from all participants. The 305	
study protocol was approved by the Ethics Committee for Pediatrics, Adolescent Medicine 306	
and Psychiatry, Hospital District of Helsinki and Uusimaa (570/E7/2003). UK ethical 307	
approval was granted by the London-Chelsea NRES committee (13/LO/0257). The study was 308	
conducted in accordance with the guidelines of The Declaration of Helsinki. 309	
 310	
Genetic Analysis  311	
Genetic analysis was performed in 67 probands with DP, from those 67 families with the 312	
greatest number of affected individuals in our cohort, (male n=57, female n=10), 58 affected 313	
family members (male n=36, female n=22) and 35 of their unaffected family members (male, 314	
n=13, female n=22). Whole exome sequencing (WES) was performed on DNA extracted 315	
from peripheral blood leukocytes of these 160 individuals, using a Nimblegen V2 or Agilent 316	
V5 platform and Illumina HiSeq 2000 sequencing. The exome sequences were aligned to the 317	
UCSC hg19 reference genome using the Burrows-Wheeler Aligner software (BWA-MEM 318	
[bwa-0.7.12]. The software Picard tools [picard-tools-1.119] was used to sort alignments and 319	
mark PCR duplicates. We used the genome analysis toolkit (GATK-3.4-46) to realign around 320	
indels and recalibrate quality scores using dbSNP, Mills and 1000 genomes as reference 321	
resources. 	Variant calling and joint genotyping using pedigree information was performed 322	
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using HaplotypeCaller in GVCF mode from the genome analysis toolkit.	The resulting 323	
variants were filtered using the variant quality score recalibration (VQSR) from GATK. 324	
Variants were analysed and filtered for potential causal variants using filters for quality 325	
control, predicted function, minor allele frequency (MAF) and biological relevance (Figure 1-326	
A). Filtering by MAF included only variants with MAF <2.5% in the 1000 Genomes 327	
database, the NHLBI exome variant server and the ExAC and gnoMAD databases. Biological 328	
relevance filtering allowed prioritisation of variants in genes with potential biological 329	
significance in the control of pubertal timing, using tools including Ingenuity Variant 330	
Analysis (QIAGEN Redwood City), Genego MetaCore (Thomson Reuters), OMIM, UniProt 331	
and Annovar (35). The multiple family filter retained only genes with variants present in 332	
more than one proband, and the case-control analysis excluded variants present in more than 333	
one unaffected control from our Finnish cohort, represented by family members with timing 334	
of puberty within the normal range. Targeted exome sequencing (Fluidigm) of the remaining 335	
candidate gene post-filtering was performed in a further 42 families from the same cohort 336	
(288 individuals, 178 with DP; male=106, female=72 and 110 controls; male=55, female=55, 337	
Figure 1-A), with filtering as in (15). Whole gene rare variant burden testing was performed 338	
post sequencing. Fisher’s exact test was used to compare the prevalence of deleterious 339	
variants in our cohort with a set of controls from the Finnish population (ExAC European 340	
Finnish), taken from the ExAC Browser (Exome Aggregation Consortium (ExAC), 341	
Cambridge, MA: accessed September 2015). For each gene, all variants from the ExAC 342	
database with minor allele frequency <2.5%, predicted to be deleterious by both Polyphen-2 343	
(36) and SIFT (37), were included in the analysis, with each family in our cohort represented 344	
by the proband only. A multiple comparison adjustment was applied post hoc using the 345	
Benjamini & Hochberg method (17), as detailed in (15).  346	
 347	
16	
	
In silico analysis 348	
The mutant 3D structure of EAP1 harbouring the Asn770His variant was obtained using 349	
Phyre2 program (38) and the mutant EAP1 FASTA sequence. Protein disorder was predicted 350	
using the DISOPRED3 server (39). The human experimental structure of EAP1 (PDB: 2cs3) 351	
was used as template.  352	
Site-directed mutagenesis 353	
EAP1 mutations were inserted in pcDNA3.1/Zeo-hEAP1 (7) using QuikChange II Site-354	
Directed Mutagenesis Kit (Agilent Technologies) following the manufacturer’s instructions. 355	
The p.Ala221del in-frame deletion was inserted using the following primers: forward 5’- 356	
GCGGCGTCGGTGGCGTCTCGGCGTGGAAC -3’ and reverse 5’- 357	
GCCACCGACGCCGCTGAAGAAGAATTGGGG -3’. The p.Asn770His missense mutation 358	
was inserted using the following primers: forward 5’- 359	
CCCTAGTCGGGTCGCATGTACCTTGGGCC-3’ and reverse 5’- 360	
GGCCCAAGGTACATGCGACCCGACTAGGG -3’. RINGdel is a deletion (amino acids 361	
715-762) of the whole RING finger domain and used as a control (7). Mutations correctly 362	
inserted were checked with Sanger sequencing. 363	
 364	
Cell culture and transfection  365	
HEK293T cells (sourced from ATCC) were cultured in Dulbecco’s Modified Eagle 366	
Medium/High Glucose (DMEM; Sigma Aldrich) supplemented with 10% fetal bovine serum 367	
(FBS; Invitrogen) and 1% penicillin/streptomycin solution (Pen/Strep; Invitrogen) and 368	
incubated at 37°C in a humidified incubator with 5% CO2. 300,000 cells/well were seeded in 369	
a traditional six-well plate; after 24 hours cells were transiently transfected using 370	
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polyethylenimine (PEI 10.5 µl/µg DNA; Sigma Aldrich) with EAP1 WT and mutated vectors 371	
(1 µg/well) generated via site-directed mutagenesis. 372	
 373	
Protein extraction and Western blot analysis 374	
48 hours post-transfection cells were harvested and lysed in RIPA buffer (Radio-375	
Immunoprecipitation Assay; Sigma Aldrich) supplemented with Protease Inhibitor (Roche 376	
Diagnostics Ltd). The concentration of the cell lysates was measured by the BCA kit 377	
(Thermo Fischer Scientific) according to the manufacturer’s instructions. Equal amount of 378	
proteins was separated by SDS-PAGE (4-12% polyacrylamide NuPage BisTris gels; 379	
Invitrogen) and transferred on nitrocellulose membranes (Promega). Non-specific binding 380	
was blocked with 5% non-fat milk in PBS containing 0.1% Tween-20 (PBT). Membranes 381	
were incubated overnight at 4°C with primary antibodies diluted in 5% non-fat milk in PBT: 382	
rabbit polyclonal anti-EAP1 diluted at 1:2000 (Sigma Genosys) and mouse monoclonal anti-383	
glyceraldehyde-3-phosphate dehydrogenase (GAPDH, Santa Cruz Biotechnology), diluted 384	
1:5000. After washes in PBT, the membranes were probed with secondary antibodies 385	
(1:10,000, Licor). After washes in PBT, the membranes were scanned and analysed using the 386	
Odyssey Fc Imaging System (Licor). Experiment was repeated 3 independent times.  387	
 388	
Promoter assay 389	
HEK293T cells were plated on a 24 well plate (175,000 cells/well) and 24 hours later were 390	
transiently co-transfected with the same amount of pGL4.10[luc]GnRH vector (7) and SV-40 391	
Renilla (Promega) (150 ng /well each) in conjunction with either  i) EAP1 wild type or 392	
mutant vectors (200 ng/well) or ii) equal amount of EAP1 wild type and p.Ala221del or wild 393	
type and p.Asn770His mutants (100 ng/well each vector). The total amount of DNA 394	
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transfected was kept constant to 500 ng/well by adding the appropriate amount of 395	
pBlueScript vector (i.e. in order to test the basal activation of the signal, co-transfection of 396	
pGL4.10[luc]GnRH and SV-40 Renilla only was also performed). Cells were harvested 48 397	
hours post-transfection and assayed for luciferase using Dual Luciferase Reporter System 398	
(Promega) following the manufacturer’s instructions. Each experiment was performed in 399	
triplicate and repeated 3 independent times. Samples were processed using POLARstar 400	
Omega microplate reader and data were analysed using MARS Omega software.  401	
 402	
In situ hybridization and Immunohistochemistry 403	
Peri-pubertal mouse brains were collected from timed crosses of C57BL/6 mice. Vaginal 404	
opening and balanopreputial separation were designated as indicative of the onset of puberty. 405	
Brains were fixed in 4% paraformaldehyde (PFA) in PBS, cryoprotected in 30% sucrose in 406	
PBS, and frozen in OCT compound (VWR); 12 µm thick serial coronal sections were 407	
collected on Superfrost Plus slides (VWR). Mouse Eap1 was PCR-amplified from brain 408	
cDNAs using the following primers: Eap1 FOR: 5’ - CAGTCTTGCTACCTGTGCGA -3’, 409	
Eap1 REV: 5’ - AAGCGAGTGGTCCTTCTTGA -3’. Amplified cDNAs were cloned into 410	
the dual promoter vector pGEM-T easy (Promega) and linearized with the appropriate 411	
restriction enzymes. Probe preparation and in situ protocol were performed as previously in 412	
(40). When co-labelling was desired, after in situ hybridisation, the sections were incubated 413	
with primary antibodies (anti-GnRH, Immunostar) diluted 1:1000 in PBS–Triton 0.1%, as 414	
used in (41). After three washes with PBS–Triton 0.1%, slides were incubated with biotin-415	
conjugated goat secondary antibodies (Vector Laboratories), diluted 1:300 in PBT and, after 416	
further washes, with the avidin–biotin complex (ABC staining kit, Vector Laboratories). The 417	
sections were reacted with 3,3’-diaminobenzidine (DAB, Vector Laboratories) and mounted 418	
19	
	
in an aqueous compound formed by PBS and glycerol (3:1). Images were acquired using a 419	
Leica DM5500B microscope (Leica, Nussloch, Germany), equipped with a DCF295 camera 420	
(Leica) and DCViewer software (Leica), and then processed with Abode Photoshop CS6 and 421	
Adobe Illustrator CS6. 422	
 423	
Nonhuman primates 424	
The medial basal hypothalamus (MBH) of female rhesus monkeys (Macaca mulatta) was 425	
obtained through the Oregon National Primate Research Center (ONPRC) Tissue Distribution 426	
Program. Animals were classified into different stages of pubertal development following the 427	
criteria proposed by Watanabe and Terasawa (42). Early juvenile (EJ) animals were 9 428	
months-1.8 years of age and late juvenile (LJ) were 2-2.9 years of age. The MBH was 429	
collected by making a cut along the posterior border of the optic chiasm, a cut in front of the 430	
mammillary bodies, and two lateral cuts half-way between the medial eminence and the 431	
hypothalamic sulci, as reported. Tissues were flash frozen in liquid nitrogen and stored at -432	
80°C for later processing. 433	
 434	
Chromatin Immunoprecipitation (ChIP) Assay 435	
To study the recruitment of EAP1 to the monkey GnRH1 promoter, we performed ChIP 436	
assays using chromatin extracted from the MBH of two female rhesus monkeys.  One of 437	
these animals (1year and 65 days age) was in the early juvenile (EJ) phase, while the other (2 438	
years and 99 days age) was in the late juvenile phase of postnatal development.  The ChIP 439	
procedure was described previously (21, 43-45) and was carried out with slight 440	
modifications. Tissue cross-linking was performed by incubating the MBH fragments in 1% 441	
formaldehyde for 10 minutes at room temperature. After two additional washing steps in 442	
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PBS, MBH fragments were lysed with 200 µl SDS buffer (0.5% SDS, 50 mM Tris-HCl, 10 443	
mM EDTA) containing protease, phosphatase, and HDAC inhibitors and sonicated for 45 444	
seconds to yield chromatin fragments of approximately 500 bp using a Fisher Scientific FB 445	
705 sonicator. Size fragmentation was confirmed by agarose gel electrophoresis. The 446	
sonicated chromatin was clarified by centrifugation at 14,000 rpm for 10 min at 4°C, brought 447	
up to 1 ml in Chip Dilution Buffer (CDB) (16.7 mM Tris-HCl, pH 8.1, 150 mM NaCl, 1.2 448	
mM EDTA, 1.1% Triton X-100, and 0.01% SDS) containing protease, phosphatase, and 449	
HDAC inhibitors and stored at -80°C for subsequent immunoprecipitation. For this step, 450	
chromatin was pre-cleared with Protein A/G beads (Dynabeads, Invitrogen, Carlsbad, CA) 451	
for 1 h at 4°C. One hundred microliter aliquots of chromatin were then incubated with 5 µg of 452	
the following antibodies: rabbit anti EAP1 (custom made by SIGMA, St. Louis, MO) or anti 453	
beta Galactosidase (Cortex, Biochem, Madison, WI). Antibody-chromatin complexes and 25 454	
µl of protein A beads solution (Dynabeads, ThermoFisher, Waltham, MA) were incubated at 455	
4°C overnight with gentle agitation.  Immunocomplexes were washed sequentially with 0.5 456	
ml low salt wash buffer (20 mM Tris-HCl, pH 8.1, 150 mM NaCl, 2 mM EDTA, 1% Triton 457	
X-100 and 0.1% SDS), high salt wash buffer (20 mM Tris-HCl, pH 8.1, 500 mM NaCl, 2 458	
mM EDTA, 1% Triton X-100 and 0.1% SDS), LiCl buffer (10 mM Tris-HCl, pH 8.1, 250 M 459	
LiCl, 1% Nonidet P-40, 1% sodium deoxycholate and 1 mM EDTA), and with TE buffer (10 460	
mM Tris-HCl, pH 8.0 and 1 mM EDTA).  The immunocomplexes were eluted with 100 µl of 461	
0.1 M NaHCO3 and 1% SDS at 65°C for 45 min.  Cross-linking was reversed by adding 4 µl 462	
of 5 M NaCl and incubating at 95°C for 30 min. DNA was recovered by using the ChIP DNA 463	
Clean & Concentrator columns (Zymo Research, Irvine, CA) and stored at -80°C until 464	
subsequent PCR analysis.  All chemicals were purchased from Sigma-Aldrich (St. Louis, 465	
MO, USA). Due to the limitation of availability of primate tissue, the experiment was 466	
performed only once.  467	
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 468	
PCR detection of Chromatin Immunoprecipitated DNA 469	
The promoter region of the rhesus monkey GnRH gene (JU472587) was amplified using the 470	
forward primer GCCAGAAGCTTCCAGACATCC and the reverse primer 471	
AAGTGCAGCCATTAAAACCTCAG. As a negative control for EAP1 binding we used an 472	
intergenic region located in intron 2 of the GnRH1 gene (forward primer: 473	
ACCACGCCCGGACTGTTTC and reverse primer: TGATCCACTTACCTCGGCTTCC) 474	
(Eurofins MWG Operon, Huntsville).  PCR reactions were performed using 1 µl of each IP 475	
and Input samples and HotStart Taq Polymerase (Qiagen, Germantown, MD) in a volume of 476	
25 µl.  The thermocycling conditions used were: 95°C for 5 min, followed by 33 cycles of 15 477	
s at 95°C followed by 30 s at 55°C and 30 s at 72°C. The PCR products were run in a 1.2% 478	
Agarose gel prepared in Tris/Borate/EDTA buffer. 479	
 480	
Immunofluorescence 481	
1x105 cells/well were seeded in 4-well cell culture slide (Millipore, Fisher Scientific) and 482	
transiently transfected with 500 ng/well of WT or mutant Ala221del, Asn770His expression 483	
plasmids using PEI. 48 h after transfection, cells were fixed in 4% PFA in PBS for 15 min 484	
and washed with PBS. Samples were permeabilised with 0.1% Triton X-100 in PBS for 30 485	
min and blocked with blocking buffer (10% Normal Goat Serum in PBS) for 30 min. The 486	
staining was performed by incubating the samples with rabbit anti-EAP1 diluted at 1:1000 487	
(Sigma Genosys) in blocking buffer for 1 h, followed by a 30 min incubation with goat anti-488	
rabbit Alexa fluor 594 (ThermoFisher Scientific; 1:250) antibody. The cell nuclei were 489	
stained with 40 ,6-diamidino-2-phenylindole (DAPI, Sigma). Images were acquired using a 490	
fluorescence microscope (Leica microsystem, Germany) and processed using Adobe 491	
Photoshop CS6. 492	
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 493	
Statistical analysis 494	
For all experiments, data are expressed as the mean ± SEM. One-way repeated measures 495	
ANOVA was used to determine statistical significance for multiple comparisons; p values (*) 496	
of < 0.05 and (**) of <0.01 were considered statistically significant. A p value (***) of 497	
<0.001 was considered highly significant. The statistical analysis was performed using 498	
GraphPad Prism7 (GraphPad Software). 499	
 500	
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Figure 1. Filtering strategy to identify EAP1 as a candidate gene for self-limited DP, 644	
prediction of pathogenicity and conservation across species for EAP1 variants 645	
identified, and structural model of the zinc finger domain of EAP1. 646	
A) Whole exome sequencing was performed on DNA extracted from peripheral blood 647	
leukocytes of 160 individuals from our cohort (67 DP probands, 58 DP relatives and 35 648	
controls). The exome sequences were aligned to the UCSC hg19 reference genome. Picard 649	
tools and the genome analysis toolkit were used to mark PCR duplicates, realign around 650	
indels, recalibrate quality scores and call variants. Variants were filtered for potential causal 651	
variants using filters for quality control, predicted functional annotation, minor allele 652	
frequency (MAF), case-control analysis, variants in multiple families, and biological 653	
relevance. Targeted exome sequencing using a Fluidigm array of 28 candidate genes 654	
identified post-filtering was then performed in a further 42 families from the same cohort 655	
(288 individuals, 178 with DP and 110 controls). Variants post-targeted resequencing were 656	
filtered using the same criteria as the WES data. Rare variant burden testing was performed 657	
with a multiple comparison adjustment applied post hoc (Benjamini et al, 2001). Screening of 658	
100 further cohort controls was via conventional Sanger sequencing. DP, delayed puberty. 659	
*data published (15, 16). ** excluded due to the presence of variants in multiple controls. B)  660	
Minor allele frequencies for ExAC Finnish population (accessed February 2018), 661	
conservation, and pathogenicity scores. (SIFT(37)  Polyphen2(36)  MutationTaster(46)). 662	
M.s.a. was generated using MutationTaster (46). The p.Ala221 residue is highly conserved 663	
amongst different species, PhyloP score 1.801. The p.Asn770His is highly conserved 664	
amongst different species and the PhyloP score is 4.523. C) The mutant 3D structure of the 665	
zinc finger domain of EAP1 is presented as a cartoon. Zn atoms are presented as magenta 666	
spheres, the conserved C3HC4 residues, which bind Zn atoms, are presented in green, the 667	
mutant histidine at position 770 is presented in red.  The mutant His770, shown in red, is 668	
located on the surface of EAP1 and may be part of a protein-protein interaction site. The 669	
position of invariable residues C3HC4 is indicated with green arrows, whereas the position of 670	
N770 is indicated with a red arrow. The amino acid numbering and secondary structure is 671	
presented above the msa. C, cysteine; H, histidine, Zn, zinc; msa, multiple sequence 672	
alignment. 673	
 674	
Figure 2. Pedigrees of the families with EAP1 mutations with proband growth charts.  675	
A), B) Squares indicate male family members; circles female family members. Black 676	
symbols represent clinically affected, grey symbols represent unknown phenotype, and clear 677	
symbols represent unaffected individuals. “P” indicates the proband in each family and ‘us’ 678	
indicates un-sequenced due to lack of DNA from that individual. A horizontal black line 679	
above an individual's symbol indicates they are heterozygous for that mutation as confirmed 680	
by either whole exome sequencing or Fluidigm array, and verified by Sanger sequencing. 681	
Panels A’)-A’’); B’)-B’’): Height and height standard deviation score (SDS) charts for 682	
the probands of each of the two pedigrees. Tanner genital stage (G stage), Tanner pubic hair 683	
stage (P stage), testicular volume, Standardised (S)-testosterone, luteinising hormone (LH) 684	
and follicular stimulating hormone (FSH) values are given for each proband at various time 685	
points. Normal values, based on data from >70,000 healthy Finnish children, have been 686	
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previously published (15).  TH – target height based on mid-parental heights. Green dots 687	
connected by continuous black lines indicate bone age at the corresponding chronological age 688	
(blue dots), as estimated by the Greulich and Pyle method. 689	
 690	
Figure 3. Eap1 mRNA is expressed in the hypothalamus of peri-pubertal mice.  691	
Peri-pubertal mice hypothalamus sections were used for in situ hybridisation and 692	
immunohistochemistry to localise Eap1 mRNA (staining in purple) and GnRH neurons 693	
(staining in brown), respectively. Eap1 is expressed in the VMH, Arc and Pa nuclei of A) 694	
male and B) female mice. GnRH neuron bodies are dispersed predominantly in the MPA C) 695	
in an Eap1 positive milieu. GnRH neuron bodies are shown at higher magnification in D). 696	
GnRH neuron projections are also detected in the ME A) and at the level of the 3V C). Sense 697	
probe was used as a negative control with no detectable staining E). Arrows indicate GnRH 698	
neurons bodies. ♀: female; ♂: male; VMH: ventromedial nucleus; 3V: third ventricle; Arc: 699	
arcuate nucleus; Pa: paraventricular nucleus; AHC: anterior hypothalamic area, central part; 700	
ME: median eminence; MPA: medial preoptic area; VMPO: ventromedial preoptic nucleus. 701	
 702	
Figure 4. EAP1 binding to the GnRH promoter increases at puberty of female rhesus 703	
monkeys. 704	
An increased association of EAP1 to the rhesus GnRH1 promoter region in the MBH of 705	
female monkeys between the early juvenile (EJ) and late juvenile (LJ) periods is 706	
demonstrated. No change in EAP1 binding is detected in intron 2 of the GnRH gene. 707	
Inp=Input DNA, bGal= ChIP performed using an antibody to beta Galactosidase (a protein 708	
not present in the brain), serves as a negative control.  Experiment was performed once, due 709	
to the limitation of availability of primate tissue. 710	
 711	
Figure 5. EAP1 mutations impair the transcriptional activity of the human GnRH 712	
promoter.  713	
A) HEK293T cells were seeded at 17.5x104 cells/well onto a 24-well plate and transiently 714	
transfected with EAP1 plasmids (WT and mutated; 200 ng/well). 48 hours post transfection 715	
DLR assay was performed. Each transfection was normalised by co-transfecting with Renilla 716	
SV-40 vector and was performed in triplicate. EAP1 trans-activating GnRH promoter activity 717	
is significantly reduced by the in frame deletion (pAla221del) and missense (Asn770His) 718	
mutants compared to the WT. The mutants also cause a dose-dependent reduction of EAP1 719	
WT transcriptional activity. The ablation of the RING finger domain (RINGdel) impairs the 720	
ability of trans-activating GnRH promoter and was used as a control, n=3.  B) HEK293T 721	
cells were seeded at 0.3x106 cells/well onto a 6-well plate and transiently transfected with 722	
EAP1 plasmids (WT and mutated; 1 µg/well). 48 hours post transfection Western blot 723	
analysis was performed. Eap1 protein expression is detected at the expected molecular weight 724	
(90 KDa) and RINGdel expression is detected at approximately 80 KDa, as a result of the 725	
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deletion of the RING finger domain (amino acids 715-762). GAPDH was used as loading 726	
control and detected at 37 KDa. HEK293T cells do not express EAP1, n=3 C) Quantification 727	
of western blot analysis, indicating that Ala221del protein levels are significantly reduced 728	
and Asn770His protein levels are significantly increased.  729	
 730	
Figure 6. EAP1 p.Asn770His mutant is sub-cellularly mis-located. 731	
Immunofluorescence staining of EAP1 WT and mutated proteins (red) and DAPI (blue) in 732	
HEK293T cells. A), B), C) show EAP1 WT protein expression within the nucleus, co-733	
localising with DAPI. D), E), F) show EAP1 Ala221del mutant protein expressed within the 734	
nucleus, co-localising with DAPI. G), H), I) show EAP1 Asn770His mutant protein not 735	
expressed in the nucleus. Images were acquired using a fluorescence microscope (Leica 736	
microsystem, Germany) and processed using Adobe Photoshop CS6, n=2. 737	
